container

Focus on Improving Workflow Efficiency to Drive the Global Clinical Diagnostics Automation Market, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Clinical Diagnostics Automation markets. Global market for Clinical Diagnostics Automation is forecast to exceed US$10 billion by 2020, driven by shortage of qualified laboratory technologists, increased focus of laboratories on improving workflow efficiency and reducing operational costs.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Clinical Diagnostics Automation: A Global Strategic Business Report

San Jose, California (PRWEB) June 03, 2014

Follow us on LinkedIn – Clinical diagnosis is both an expensive and time consuming process which involves obtaining samples, analyzing them to final reporting. Clinical diagnostic laboratories across the world are exploring ways to improve productivity with smaller budgets, against the backdrop of declining government reimbursement rates for laboratory testing, cost-cutting measures adopted by managed care organizations, and the general emphasis on reducing healthcare costs. Automation has therefore emerged as key towards achieving cost efficiencies and enhanced productivity. Automation in clinical laboratories involves replacement of manual, error-prone techniques with automated processes that involve minimal operator intervention. The need to improve workflow against a backdrop of increasing number of diagnostic tests being performed is additionally driving the business case for clinical automation.

Decline in the popularity of diagnostic medicine as a career, aging workforce, reduction in the number of medical technology training programs, and sub-standard wages for medical technologists are factors aggravating shortage of qualified laboratory technologists and driving labs towards automation. Increase in annual testing volumes due to aging global population, diagnostic and testing procedure innovations, and emerging challenges in the form of detection and identification of multidrug-resistant microorganisms are fueling demand for automation of clinical diagnostics in laboratories. Growing demand for high-quality healthcare and emphasis on reducing length of stay at hospitals are also raising demand for infectious disease assays with rapid turnaround times. Several clinical labs across the world have already incorporated automation in some form to achieve higher profits and provide better patient care.

While modular automation is likely to continue finding favor among labs, few large-scale labs will take up implementation of Total Laboratory Automation. With more and more labs adopting automation, demand is expected to increase for standardized interfaces that will allow systems of multiple manufacturers to be linked and operated without any compatibility issues. Increasing adoption of modular automation is also enhancing the significance of standardization in laboratory settings.

As stated by the new market research report on Clinical Diagnostics Automation, the United States represents the single largest market worldwide. The need to lower turnaround times and enhance laboratory efficiency in order to ensure timely delivery of diagnostic findings and an aging workforce represent factors driving growth in the country. Asia-Pacific is forecast to spearhead global growth with a CAGR of 8.6% over the analysis period. Expanding population, economic prosperity, increasing healthcare spending, and rising testing needs are fuelling adoption of laboratory automation systems in the region.

Major players covered in the report include Abaxis Inc., Abbott Diagnostics Inc., Beckman Coulter Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Diagnostica Stago, Eppendorf AG, F Hoffmann-La Roche Ltd., HORIBA ABX SAS, Hudson Robotics Inc., Ortho Clinical Diagnostics Inc., PerkinElmer Inc., QIAGEN NV, Siemens Healthcare Diagnostics Inc., Sysmex America Inc., Tecan Group Ltd., The ELITechGroup SAS, and Thermo Fisher Scientific Inc., among others.

The research report titled “Clinical Diagnostics Automation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, regulations, issues, challenges, mergers, acquisitions, and other strategic industry activities of major players worldwide. The report provides market estimates and projections in dollars for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of World. Segments analyzed include Automated Analyzers, Total Lab Automation and Stand-alone Automation.

For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Clinical_Diagnostics_Automation_Market_Report.asp.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###


Contact

  • Raghu Gopal
    Global Industry Analysts Inc
    +1 408-528-9966
    Email

Attachments